Skip to content

Implementation of Hysteroscopy in Flanders and the Netherlands

Implementation of Hysteroscopy in Flanders and the Netherlands

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02853695
Enrollment
249
Registered
2016-08-03
Start date
2016-08-31
Completion date
2017-06-30
Last updated
2019-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adhesiolysis, Hysteroscopy, Minimally Invasive Surgical Procedures, Myoma, Placental Remnant, Polyp, Uterine Septum

Keywords

Hysteroscopy, Diffusion, Implementation, Diagnostic hysteroscopy, Operative hysteroscopy

Brief summary

By means of a questionnaire the investigators will study the implementation of hysteroscopy in Flanders and the Netherlands

Detailed description

Hysteroscopy is a minimally invasive method for diagnosis and treatment of intra-uterine abnormalities. Complication and failure rates are low because of the direct visualisation of the treated abnormality. Moreover, hysteroscopic procedures replaced 'blind' (curettage) and more invasive interventions (hysterectomy). The field of hysteroscopy has developed over the years. Changes occurred in hysteroscopic instruments and in the use of energy sources. An important development is the smaller diameter of the hysteroscopic system which makes it suitable for an outpatient setting. Not every gynaecologist, however, has the appropriate hysteroscopic skills or setting to carry out these procedures. The incorporation of hysteroscopic procedures into daily practice in Flanders is unclear. In the Netherlands 2 surveys were conducted in the past to question the treatment options for polypectomy in an outpatient setting on the one hand and the diffusion of hysteroscopy on the other hand. The investigators want to study the diffusion of hysteroscopy in Flanders and the Netherlands. Moreover the investigators want to provide an overview of the hysteroscopic procedures implemented, as well as the setting they are performed in. An electronic questionnaire (LimeService) will be sent to all gynaecologists in Flanders and the Netherlands. Participation is voluntary and anonymous. After informed consent all gynaecologists are asked to complete the first part of the questionnaire containing general information. The second part is specific for gynaecologists performing hysteroscopy themselves, and inquires about the procedures they carry out.

Interventions

None listed

Sponsors

Dutch Society of Obstetricians and Gyneacologists (NVOG)
CollaboratorUNKNOWN
Catharina Ziekenhuis Eindhoven
CollaboratorOTHER
Vlaamse Vereniging voor Obstetrie en Gynaecologie
CollaboratorOTHER
University Ghent
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* gynaecologist

Exclusion criteria

* residents in training for gynaecology/obstetrics

Design outcomes

Primary

MeasureTime frameDescription
Questionnaire: Implementation of hysteroscopyAugust 2016, questionnaire will be sent once at the start of the studythe amount of gynaecologists performing hysteroscopy in relation to the total of gynaecologists participating in the questionnaire

Secondary

MeasureTime frameDescription
Questionnaire: setting for performing diagnostic hysteroscopyAugust 2016, questionnaire will be sent once at the start of the studyin which setting (office/operating room) diagnostic hysteroscopies are performed in relation to the total amount of diagnostic hysteroscopies performed
Questionnaire:Instrumentation used for hysteroscopyAugust 2016, questionnaire will be sent once at the start of the studywhich instrumentation is used for specific hysteroscopic procedures.
Questionnaire: Diagnostic and techniques in the treatment of intrauterine pathologyAugust 2016, questionnaire will be sent once at the start of the studywhich diagnostics and techniques are used in the treatment of intrauterine pathology

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026